Hospitalist Doctors in Derry, NH Accepting Medicare

4 Hospitalist doctors found. Showing 1 - 4

Hiral H Patel, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1 Parkland Dr, Derry, NH 03038 Phone: 603-432-1500    Fax: 603-421-2344

Alaa Azzouqa, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Parkland Dr, Derry, NH 03038 Phone: 603-432-1500

Dr. Michael Patrick Marolda, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd Ste 100, Derry, NH 03038 Phone: 603-537-1300

Ciara Kazakis, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6 Tsienneto Rd, Suite 300, Derry, NH 03038 Phone: 603-216-0400    Fax: 603-216-3800

News Archive

Public opinion is unified on lowering prescription drug prices. Why are leaders settling for less?

Democrats and Republicans are crystal clear in polls that they want government to be allowed to negotiate down high drug prices. Americans pay nearly three times as much for drugs as patients in dozens of other countries.

Computer simulations show how two knots on DNA strand can interchange positions

Physicists of Johannes Gutenberg University Mainz and the Graduate School of Excellence "Materials Science in Mainz" (MAINZ) have been able with the aid of computer simulations to confirm and explain a mechanism by which two knots on a DNA strand can interchange their positions.

Virtual 'moonwalk' causes distortions in spatial memory

In order to remember where important events happened, or how to get from A to B, our brains form mental "maps" of our environment. An important component of these mental maps are the so-called grid cells.

SDCL researchers to use BioMark equipment to test for infectious diseases

Saskatchewan patients will benefit from faster, more accurate disease identification, thanks to a ground-breaking new technology in infectious disease testing at the Saskatchewan Disease Control Laboratory.

Current criteria for ALK positive lung cancer needs to be redefined

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

Read more Medical News

› Verified 7 days ago